Subject(s)
Cancer Care Facilities/trends , Health Services Accessibility , Radiation Oncology/trends , Armed Conflicts/statistics & numerical data , Cancer Care Facilities/supply & distribution , Colombia , Forecasting , Geography , Health Care Costs , Humans , Internship and Residency/economics , Internship and Residency/statistics & numerical data , Particle Accelerators/supply & distribution , Private Sector , Public Sector , Quality Improvement , Radiation Oncologists/education , Radiation Oncologists/supply & distribution , Radiation Oncology/economics , Radiation Oncology/education , Rural Health Services/supply & distribution , Transportation/standards , Universal Health Insurance/classification , Universal Health Insurance/economics , Universal Health Insurance/statistics & numerical dataABSTRACT
It has been hypothesised that the reimbursement system pertaining to radiotherapy is influencing prescription practices for patients with cancer with bone metastases. In this paper, we present and discuss the results of an empirical study that was undertaken on patient records, referred to radiotherapy for the treatment of bone metastases, in a medium-size city, in southern Brazil, during the period of March 2006 to March 2014. Our findings seem to confirm this hypothesis: after a change in the reimbursement method, radiation prescriptions were adapted accordingly, in order to maximise profits. Once such patients become highly vulnerable due to their diagnoses, they also become susceptible to a subtle form of exploitation; physicians let patients believe that more radiation will be better for their health, and they do so despite knowing otherwise, and as it seems, out of pecuniary interests.
Subject(s)
Bone Neoplasms/secondary , Practice Patterns, Physicians'/economics , Radiation Oncology/economics , Reimbursement, Incentive/statistics & numerical data , Bone Neoplasms/radiotherapy , Brazil , Health Care Surveys , Humans , Practice Patterns, Physicians'/ethics , Practice Patterns, Physicians'/statistics & numerical data , Radiation Oncology/ethics , Radiation Oncology/trends , Reimbursement Mechanisms , Reimbursement, Incentive/economics , Reimbursement, Incentive/ethics , Vulnerable PopulationsABSTRACT
In this paper, we report our experimental design in searching a smart and easy-to-read dosimeter used to detect 6 MV X-rays for improving patient safety in radiation oncology. The device was based on an organic emissive solutions of poly(2-methoxy-5(2'-ethylhexyloxy)-p-phenylenevinylene) (MEH-PPV), aluminum-tris-(8-hydroxyquinoline) (Alq3) and additive components which were characterized by UV-Vis absorption, photoluminescence and CIE color coordinate diagram. The optical properties of MEH-PPV/Alq3 solutions have been examined as function of radiation dose over the range of 0-100 Gy. It has shown that MEH-PPV/Alq3 solutions are specifically sensitive to X-rays, since the effect of radiation on this organic system is strongly correlated with the efficient spectral overlap between Alq3 emission and the absorption of degraded MEH-PPV, which alters the color and photoemission of MEH-PPV/Alq3 mixtures from red to yellow, and then to green. The rate of this change is more sensitive when MEH-PPV/Alq3 is irradiated in the presence of benzoyl peroxide than when in the presence of hindered phenolic stabilizers, respectively, an accelerator and an inhibitor to activate or inhibit free radical formation. This gives rise to optimize the response curve of the dosimeter. It is clear from the experimental results that organic emissive semiconductors have potential to be used as dedicated and low-cost dosimeters to provide an independent check of beam output of a linear accelerator and therefore to give patients the opportunity to have information on the dose prescription or equipment-related problems a few minutes before being exposed to radiation.